Guilherme Nader-Marta, MD, and Erica L. Mayer, MD, MPH, discusses innovative treatments for HR-positive, HER2-negative metastatic breast cancer.
Guilherme Nader-Marta, MD
Advertisement
Guilherme Nader-Marta, MD is an advanced Clinical Fellow at Dana-Farber Cancer Institute.
Articles by Guilherme Nader-Marta, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
The Role of Elacestrant in ER+/HER2– Advanced Breast Cancer Harboring ESR1 Mutations
2
Nemtabrutinib With Venetoclax Shows Promising Activity in R/R CLL/SLL
3
Pembrolizumab Fails to Yield Responses in Recurrent Medullary Thyroid Cancer
4
Dr Raghav on the Rationale for Investigating Telisotuzumab Adizutecan in ctDNA+ CRC
5